Literature DB >> 12426416

Methylphenidate treats apathy in Parkinson's disease.

Anjan Chatterjee, Stanley Fahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12426416     DOI： 10.1176/jnp.14.4.461

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  20 in total

Review 1.  Recognition and management of neuropsychiatric complications in Parkinson's disease.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

2.  Motivational engagement in Parkinson's disease: Preparation for motivated action.

Authors:  J B Renfroe; M M Bradley; M S Okun; D Bowers
Journal:  Int J Psychophysiol       Date:  2015-12-01       Impact factor: 2.997

Review 3.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 4.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

5.  Methylphenidate : a treatment for Parkinson's disease?

Authors:  David Devos; Caroline Moreau; Arnaud Delval; Kathy Dujardin; Luc Defebvre; Regis Bordet
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

Review 6.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 7.  Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

Authors:  Jens Volkmann; Christine Daniels; Karsten Witt
Journal:  Nat Rev Neurol       Date:  2010-08-03       Impact factor: 42.937

8.  Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.

Authors:  Trent J Volz; Sarah J Farnsworth; Glen R Hanson; Annette E Fleckenstein
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

10.  Major depressive disorder preceding the onset of progressive supranuclear palsy.

Authors:  Won-Hyoung Kim; Young-Soo Lee; Seung-Ho Jung; Hye-Jin Choi; Myung-Ji Lee; Min-Hee Kang; Chul-Eung Kim; Jeong-Seop Lee; Jae-Nam Bae
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.